Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 234

Results For "EMA"

2996 News Found

MilliporeSigma acquires MAST platform from Lonza
Biotech | April 06, 2022

MilliporeSigma acquires MAST platform from Lonza

MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies


Revenue growth to moderate, non-Covid-19 revenue to drive profitability
News | April 06, 2022

Revenue growth to moderate, non-Covid-19 revenue to drive profitability

Ind-Ra maintains a neutral outlook for healthcare in FY23


Aster MIMS Hospital completes 50 kidney swap transplants
Hospitals | April 06, 2022

Aster MIMS Hospital completes 50 kidney swap transplants

The kidney swap transplant procedure provides a solution to a critical shortage of compatible kidneys for patients suffering from kidney failures in India


Aizon partners with TetraScience to help pharma companies speed up drug manufacturing efficiently
Biotech | April 06, 2022

Aizon partners with TetraScience to help pharma companies speed up drug manufacturing efficiently

The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation


AGC to invest $100 million for expanding synthetic pharmaceutical production in Spain
News | April 06, 2022

AGC to invest $100 million for expanding synthetic pharmaceutical production in Spain

The new facility is scheduled to start operation in the first half of 2024


Trescal launches its single source calibration solution across Australia and New Zealand
Biotech | April 05, 2022

Trescal launches its single source calibration solution across Australia and New Zealand

Trescal provides precision calibration expertise in every industry, geography and instrument across the world


Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Biotech | April 05, 2022

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)


BSV strengthens women's health portfolio by acquiring Tidilan brand
News | April 05, 2022

BSV strengthens women's health portfolio by acquiring Tidilan brand

It is currently available in tablet and injectable dosage forms


Merck expands manufacturing facility in Virginia to increase HPV vaccine supply
Biotech | April 04, 2022

Merck expands manufacturing facility in Virginia to increase HPV vaccine supply

Supply increase to help meet growing global demand


Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar
Biotech | April 04, 2022

Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar

Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US